Ikervis
New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs
December 16, 2015Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin
NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …
New treatments to boost dry eye drug market – if approved
November 5, 2015Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast
The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …
NICE asks for more evidence from dry eye treatment maker
June 24, 2015Research and Development, Sales and Marketing Ikervis, NHS, NICE, ciclosporin, santen pharma
A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
